Objective-This study examines the hypothesis that chronic inflammation is associated with a higher risk of cardiac death compared to the risk of nonfatal myocardial infarction. Methods and Results-Cardiac death and nonfatal MI events were identified in the ARIC cohort during follow-up from 1987 through 2001. Markers of inflammation and hemostasis were determined at baseline using standardized procedures. Cox proportional hazard regression and polytomous logistic regression were used to estimate associations. We observed a positive gradient in incidence of sudden cardiac death (SCD), nonsudden cardiac death (NSCD), and nonfatal MI in association with decreasing levels of albumin and increasing levels of white blood cell count and of markers of hemostasis (fibrinogen, von Willebrand factor, factor VIIIc 
I
nflammation and hemostasis play a central role in the development and progression of atherosclerotic lesions. [1] [2] [3] Chronic inflammation, associated with conditions such as smoking, diabetes, hypertension, and obesity, promotes expression of proinflammatory cytokines, attracting leukocytes and monocytes to the developing plaque. 4 Systemic markers of inflammation are associated positively with risk of cardiovascular events in both cross-sectional and prospective studies. [5] [6] [7] [8] [9] [10] [11] Likewise, increased levels of circulating markers of hemostasis are associated with increased risk of secondary cardiovascular events, and to a lesser extent increased risk of primary events. 5, 8, 12 Few prospective studies have explored differences in the association of markers of inflammation and hemostasis with different coronary heart disease outcomes. In this study, we used data from the Atherosclerosis Risk in Communities (ARIC) cohort to examine the association of the following selected markers of inflammation and hemostasis: white blood cell count, serum albumin, plasma fibrinogen, von Willebrand factor and Factor VIIIc, with the risk of nonfatal myocardial infarction, nonsudden cardiac death, and sudden cardiac death.
Methods

Study Population
The ARIC cohort is a biracial cohort, consisting of 15 792 men and women, 45 to 64 years of age at baseline (1987 to 1989), selected as probability samples from 4 U.S. communities located in North Carolina, Mississippi, Minnesota, and Maryland. 13 Follow-up of the ARIC cohort members is conducted annually through telephone interviews. In addition, 3 triennial follow-up visits were conducted after the baseline data collection.
The present study is based on data obtained at baseline (1987 to 1989) and during follow-up through December 31, 2001 . We eliminated from analysis (exclusions not mutually exclusive) persons who did not report a black or white race on their baseline questionnaire (nϭ48), the small number of persons who were black and residing in the Minnesota or Maryland communities (nϭ55), persons missing outcome information (nϭ9), persons with coronary heart disease identified at baseline (nϭ766), or those missing baseline CHD information (nϭ344), as well as persons missing baseline information on the following exposures and selected analysis covariates: fibrinogen (nϭ276), von Willebrand factor (nϭ289), factor VIIIc (nϭ297), white blood cell count (nϭ246), albumin (nϭ150), cigarette smoking status (nϭ11), and cigarette years of smoking (nϭ279). The final analysis cohort consisted of 14 009 ARIC cohort members.
Baseline Measurements
Physical examination of the cohort members and assessment of their risk factor was conducted during the baseline visit. Members of the ARIC cohort had blood drawn from an antecubital vein into tubes containing EDTA (lipids), sodium citrate (hemostatic assays), or a separating gel (glucose and albumin). Plasma HDL-cholesterol levels were measured using the method of Warnick et al. 14 Plasma total cholesterol levels were determined enzymatically 15 using a Cobas-Bio analyzer with reagents purchased from Boehringer Mannheim Biochemicals. White blood cell count was determined in the whole blood sample using a Coulter Counter. Plasma levels of fibrinogen, von Willebrand factor, and factor VIIIc were determined in the ARIC Central Hemostasis Laboratory using established procedures. 16 Plasma fibrinogen levels were determined using the thrombin time titration method, with reagents obtained from General Diagnostics Organon Technica Co. von Willebrand factor antigen was determined using ELISA kits from American Bioproducts Co. Factor VIII activity was determined on the basis of a coagulation titration curve established using factor VIII-deficient plasma (George King Biochemical Inc). Reliability coefficients for measurement of the hemostatic factors in a sample of ARIC study participants conducted over several weeks were 0.68 for von Willebrand factor, 0.86 for Factor VIIIc, and 0.72 for fibrinogen. 10, 16 Intra-and interassay coefficients of variations for all hemostatic and inflammatory variables were lower than 5%. 17, 18 Body mass index was calculated as the ratio of weight in kilograms to height in meters squared. Sitting blood pressure was measured 3 times using a random zero sphygmomanometer. Blood pressure calculations were made as an average of the second and third measurement. Hypertension was defined as present, based on use of antihypertensive medication within 2 weeks of baseline data collection, or systolic blood pressure greater than or equal to 140 mm Hg or diastolic blood pressure greater than or equal to 90 mm Hg. Baseline diabetes was defined as either a self-reported physician's diagnosis of diabetes, use of hypoglycemic medications, nonfasting serum glucose levels greater than or equal to 11.1 mmol/L, or fasting (Ն8 hours) serum glucose level greater than or equal to 7.0 mmol/L.
Highest attained level of education was defined on the basis of a personal report at baseline of the highest grade completed in school and categorized as low (11th grade or less) or high (12th grade and above).
Outcome Ascertainment
Incident Sudden Cardiac Death Cases
All deaths attributed to coronary heart disease in the main ARIC adjudication were reviewed to ascertain whether each event was attributable to sudden cardiac death. These cases underwent a separate physician panel review using a uniform abstraction form to determine whether the death was characterized as a sudden, pulseless condition without a known noncardiac cause. Adjudication was performed independently by 2 physicians on the basis of data obtained from death certificates, informant interviews, physician questionnaires, coroner reports, or hospital discharge summaries.
This review was performed for both in-and out-of-hospital deaths. Interreviewer reliability was evaluated in a subset of cases. The kappa coefficient describing the classification of sudden cardiac death between the 2 physician reviewers was 0.79. Initial discordant classification was resolved by a third independent review.
Incident Nonsudden Cardiac Death
Incident nonsudden cardiac death cases, identified during follow-up, were defined as those cases of death meeting ARIC study criteria for definite fatal myocardial infarction or definite or possible fatal coronary heart disease, 13 which did not meet sudden cardiac death criteria.
Incident Nonfatal Myocardial Infarction
Incident nonfatal myocardial infarction, defined by the ARIC study criteria, 13 was identified during follow-up through annual questionnaires, review of medical discharge records (presence of chest pain, cardiac biomarkers, electrocardiograms), or at follow-up examinations. 13, 19 
Statistical Analysis
Age-adjusted incidence rates were calculated per tertiles of distribution of von Willebrand factor, Factor VIIIc, fibrinogen, albumin, and white blood cell count. Regression analysis was performed using Cox proportional hazard models of the association of marker tertiles with the hazard of sudden cardiac death, nonsudden cardiac death, or nonfatal MI. The following baseline variables: age, race/ARIC center, body mass index, gender, diabetes, cigarette years of smoking, cigarette smoking status, systolic blood pressure, use of antihypertensive medication, total cholesterol, and HDL-cholesterol were evaluated for inclusion into regression models on the basis of existing literature and retained according to a 10% change-inestimate criterion. 20 The race/ARIC center variable was created as a categorical variable encompassing five categories of race and ARIC center. Potential interaction terms were evaluated using partial likelihood ratio tests based on nested models. All continuous variables were evaluated for linearity of association with the main outcome. The Cox proportional hazard assumption was examined for all variables individually and for the final model using the Cox test and on the basis of ln-ln plots and plots of scaled Schoenfeld residuals. Nominal polytomous logistic regression analysis was used to address the question of competing risk of cardiac death in the analysis of the risk of nonfatal MI. All analyses were performed using STATA 10.0 (STATA Corp).
Results
Cohort participants, whose levels of von Willebrand factor, factor VIIIc, fibrinogen, and white blood cell count were in the highest tertiles of distribution, and whose albumin levels were in the lowest tertile of the distribution, shared the following characteristics. They were on average older, had higher BMI values, and had higher baseline glucose levels than those cohort participants whose levels of the markers of inflammation and hemostasis were in the lowest (highest for albumin) tertile of distribution (Table 1) . Prevalence of ever smoking and of diabetes and hypertension was higher among those with highest, as compared to the lowest, levels of von Willebrand factor, factor VIIIc, fibrinogen, and white blood cell count, and lowest levels of albumin. Those differences were statistically significant at Pϭ0.05.
In Kaplan-Meier cumulative survival analysis, adjusted for age and stratified by tertiles of selected markers, increased levels of fibrinogen, white blood cell count, Factor VIIIc, and von Willebrand factor showed an association with increased risk of nonfatal MI and sudden cardiac death and to a lesser extent with increased risk of nonsudden cardiac death. For nonfatal MI, the risk was most pronounced for high levels of fibrinogen and white blood cell count. In the case of sudden cardiac death, the pattern of risk was observed to be similar for all 5 markers. Patterns of risk of nonsudden cardiac death in strata of the examined marker tertiles were similar to those observed for nonfatal MI; although the cumulative survival proportion was considerably lower ( Figure 1 ).
The age-adjusted rate of incidence of nonfatal MI (NFMI) was consistently higher than that of sudden (SCD) or nonsudden (NSCD) cardiac death overall and across all exposures (overall incidence rates [IR) per 10,000 person-years : IR SCD ϭ11. Table 2 ). The age-adjusted incidence rates for sudden and nonsudden cardiac death were similar in magnitude across all exposure categories. Incidence of sudden cardiac death, nonsudden cardiac death, and nonfatal MI increased across increasing tertiles of von Willebrand factor, factor VIIIc, fibrinogen, and white blood cell count and across decreasing tertiles of serum albumin, with a greater difference in incidence rates between the second and third tertile, as compared to the first and second tertile for all exposures except albumin.
In analyses stratified by gender, men had significantly higher crude rates of incidence of sudden cardiac death and nonfatal MI than women, overall, and for all exposure categories. There were no significant gender-differences in rates of nonsudden cardiac death, either overall or across exposure categories. For all exposures examined, the rates of sudden cardiac death and nonsudden cardiac death were higher among blacks, as compared to whites. There were no significant race differences in the rates of nonfatal MI overall and across exposure categories (race and gender stratified data not shown).
We examined the association of the selected markers of hemostasis and inflammation with the risk of nonfatal MI, sudden cardiac death, and nonsudden cardiac death in tertiles of marker distribution using Cox proportional hazard regression models adjusted for the following covariates: age, gender, race ARIC center, cigarette years of smoking, and cigarette smoking status. The hazard ratios for sudden cardiac death, nonsudden cardiac death, and nonfatal MI increased across exposure levels for all exposure categories ( Table 3) . The hemostatic markers, von Willebrand factor and fibrinogen and inflammatory markers, white blood cell count, and albumin, were associated strongly with the risk of sudden cardiac death and of nonsudden cardiac death. The association of factor VIIIc with the risk of nonsudden cardiac death was modest and not statistically significant. With respect to nonfatal MI, we observed modest associations for von Willebrand factor, factor VIIIc, white blood cell count, and albumin, and a strong association for fibrinogen. Adjustment for the following covariates associated with CHD outcomes: diabetes, total cholesterol, HDL-cholesterol, systolic blood pressure, and use of antihypertensive medication, in addition to the demographic variables and smoking, did not significantly alter estimates for the risk of sudden cardiac death, but attenuated the estimates for the associations of the highest, as compared to the lowest tertiles, of fibrinogen with the risk of 
]).
Likelihood ratio tests of nested models with and without gender and race interaction terms, as well as analyses of joint and independent effects, suggested that neither race nor gender modified the association of albumin, white blood cell count, fibrinogen, von Willebrand factor, and factor VIIIc with the risk of sudden cardiac death, or nonsudden cardiac death, or nonfatal MI.
Sensitivity Analyses
Because cigarette smoking contributes significantly to the level of chronic systemic inflammation, we examined the associations of the selected markers of inflammation and hemostasis with the risk of cardiac death and nonfatal MI among never smokers and among ever-smokers. We did not observe a significant difference in the point estimates among never-smokers as compared to the total sample population, suggesting a negligible effect modification by smoking of the association of the selected markers of inflammation and hemostasis with sudden or nonsudden cardiac death, or nonfatal MI (Figure 2 ). Likelihood ratio tests of the interaction of smoking status with all exposures were nonsignificant for all outcomes.
Model 2 shown in Table 3 represents association of tertiles of the selected markers with the risk of CHD outcomes adjusted for the demographic covariates and for smoking. Incorporation of baseline diabetes, a condition associated with chronic inflammatory states and advanced atherosclerosis, into this model only slightly attenuated the estimates of the hazard ratios for sudden cardiac death, nonsudden cardiac death, and nonfatal MI in association with all selected exposures.
Inclusion of education, or of median household income, as covariates in the Cox regression models, did not alter the estimates of risk associated with any of the exposures.
Exclusion of persons with prevalent heart failure (nϭ540) or those with baseline diagnosis of atrial fibrillation (nϭ22) did not alter the estimates of the association of the selected inflammatory and hemostatic markers with either fatal or nonfatal CHD events.
Baseline hemostatic and inflammatory factors were also associated with noncardiac mortality, although the relative strength of the association was lower than for cardiac death. Hazard ratios of noncardiac death, adjusted for age, gender, race, ARIC center, and smoking, for the highest versus the lowest tertiles of von Willebrand factor and factor VIIIc with the risk of noncardiac death were 1.72 (95% CI 1.50, 1.98) and 1.88 (95% CI 1.64, 2.15), respectively. We performed polytomous logistic regression to confirm, or refute, observations obtained with single end point models (Table 4) . Regression was performed with coronary heart disease events categorized as follows: nonfatal MI not followed by cardiac death, sudden cardiac death not preceded by a nonfatal MI, nonsudden cardiac death not preceded by a nonfatal MI, sudden cardiac death after a nonfatal MI, or nonsudden cardiac death after a nonfatal MI. There were 21 cases of sudden cardiac death and 17 cases of nonsudden cardiac death which were preceded by a nonfatal MI. Those numbers are too small for a meaningful analysis of effects stratified by exposure categories. We therefore focused analysis on the 3 independent outcomes: sudden and nonsudden cardiac deaths and nonfatal MI. Results of this multinomial analysis, presented in Table 4 , confirmed results from individual analyses suggesting a stronger association of von Willebrand factor and factor VIII with the risk of sudden and nonsudden cardiac death as compared to the risk of nonfatal MI. A formal test of the null hypothesis that the strength of the association is the same for the 3 outcomes indicated a significant difference in the association of von Willebrand factor with sudden (PϽ0.01) and nonsudden (PϽ0.01) cardiac death as compared to nonfatal MI and a significant difference in the association of factor VIIIc with sudden (PϽ0.01) and nonsudden (PϽ0.01) cardiac death as compared to nonfatal MI.
Discussion
In this study, we observed a positive association of high white blood cell count, fibrinogen, von Willebrand factor, and of factor VIIIc and a negative association of high albumin with increased incidence of fatal and nonfatal coronary heart disease events during an average 12.4 years of follow up. Our results corroborate observations from published studies 5, [21] [22] [23] [24] [25] [26] extending previously reported ARIC study results to a longer follow-up time and providing a comparative analysis of the association of those markers with different CHD outcomes.
Presented data suggest a stronger association of von Willebrand factor with risk of cardiac death (sudden and nonsudden), as compared to the risk of nonfatal MI. Coagulation factor VIII, secreted by the liver, and to a lesser extent by the spleen and cells of the lymphatic system, exists in the circulation in the form of a stable complex with von Willebrand factor, 27,28 a multimeric glycoprotein produced primarily by the endothelium in response to injury and inflammatory stimuli. 26 This results in von Willebrand factor and factor VIIIc being highly correlated and showing almost identical associations with coronary heart disease. Binding of von Willebrand factor to the subendothelial matrix and to activated platelets facilitates platelet accumulation at the site of injury and leads to eventual formation of a thrombus plug. 29, 30 Elevated plasma levels of von Willebrand factor reflect presence of endothelial injury and dysfunction in a manner more specific than that of the other inflammatory and hemostatic markers. 31 In this study, we found that plasma levels of von Willebrand factor, although positively associated with all CHD outcomes, were more strongly associated with cardiac death (sudden and nonsudden) as compared to nonfatal MI. Those results would suggest, indirectly, a specific role of endothelial dysfunction in fatal CHD events. 32, 33 Explanations for the association of raised levels of von Willebrand factor with clinical outcomes, which in addition to coronary heart disease include stroke, 34 -36 peripheral artery disease, 37 and heart failure, 38 range from its role in thrombogenesis to promotion of atherosclerosis. Longitudinal data from the CARDIA study do not support a role for von Willebrand factor in the development of subclinical atherosclerosis. 39 Our observed preferential association of von Willebrand factor, and closely correlated with it Factor VIIIc, with fatal as compared to nonfatal CHD events, may therefore suggest greater clinical importance of thrombotic events in patients at increased risk of cardiac death. Odds ratio estimates determined by polytomous logistic regression with no events as the base category. Data presented for independent outcomes only. Analysis adjusted for age, gender, race, ARIC center, baseline smoking status, and cigarette years of smoking.
Our finding that smoking does not modify the association of von Willebrand factor, factor VIII, fibrinogen, and white blood cell count with coronary heart diseases events, confirms and extends the data of Lee et al, 21 in which the authors observed that the associations of white blood cell count with cardiovascular mortality and with the incidence of coronary heart disease were independent of smoking status.
We observed an inverse association of albumin with cardiac death, but we did not observe an independent association of albumin with incidence of nonfatal MI. These data are in agreement with the report by Kuller et al, 22 suggesting a stronger association of albumin with fatal, as compared to nonfatal CHD events.
Other studies of the association of inflammatory and hemostatic markers with fatal and nonfatal events have not been conclusive. Investigators of the Northwick Park Heart Study, in long-term follow-up of persons without prior myocardial infarction, 40, 41 observed an association of factor VII activity with fatal ischemic heart disease events, but not with nonfatal events. Those results have not been reproduced by other studies. 6, 42, 43 There were several limitations to this study. The study lacked extensive information (eg, C-reactive protein) concerning baseline inflammatory status. We examined only baseline exposure status; it was beyond the scope of this study to examine the effect of change in levels of inflammatory and hemostatic markers over the period of follow-up.
We did not examine the extent to which subclinical atherosclerosis may have affected observed associations. Measures of subclinical disease, such as coronary artery calcification, carotid artery wall thickness, or presence of atherosclerotic plaque, may be helpful in future studies examining the possible role of subclinical disease in the associations of inflammatory and hemostatic factors with CHD outcomes; however, the relatively small number of cardiac deaths in the current study would have yielded very imprecise estimates.
The strength of this study lies in its prospective design. We have observed an association of markers of inflammation and hemostasis obtained from blood samples collected at baseline with coronary heart disease events occurring during an extensive (12.4-year) follow-up period. The fact that these associations were present for different markers argues against them resulting from chance and is consistent with the presence of a sustained chronic inflammatory burden, which then impacts cardiovascular events. The definition of sudden cardiac death used in this study was constructed to best capture those cases of cardiac death that were truly sudden and unexpected and combined all available cardiac death information.
In conclusion, our observations add to the existing hypotheses concerning different roles that inflammatory and hemostatic processes may play in the development of fatal and nonfatal coronary heart disease outcomes. 42, 44 Furthermore, our results suggest that elevated plasma levels of factor VIIIc and von Willebrand factor may aid in identifying those at increased risk of sudden cardiac death. Cardiac death, particularly sudden cardiac death, 45 is often the first manifestation of underlying pathology, yet traditional risk factors do not specifically identify those at increased risk. 46 -48 Observations presented here may help clarify the role of inflammation and impairment of hemostasis in the pathology of sudden cardiac death, aid in identifying persons at increased risk, and perhaps serve as guidelines for thrombolytic therapy.
